MyAverix Finance
TWO · Healthcare
Taigen Biopharmaceuticals Holdings Ltd (4157)
Biotechnology
Taigen Biopharmaceuticals Holdings Ltd (4157) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4157
Taigen Biopharmaceuticals Holdings Ltd (4157) — FAQ
What is 4157's P/E ratio?
The price-to-earnings (P/E) ratio for Taigen Biopharmaceuticals Holdings Ltd (4157) is 25.00 (data as of 2026-05-23).
Does Taigen Biopharmaceuticals Holdings Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Taigen Biopharmaceuticals Holdings Ltd (4157). Check the MyAverix Finance app for the latest dividend data.
What sector is Taigen Biopharmaceuticals Holdings Ltd in?
Taigen Biopharmaceuticals Holdings Ltd (4157) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 4157 listed on?
4157 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.